Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Analysis-Europe's airlines pivot to bite size M&A deals to limit cost, regulatory burden
-
Form 4 Equitable Holdings, Inc. For: Feb 28 Filed by: BERNSTEIN SETH P
-
Form 4 Capital Bancorp Inc For: Mar 03 Filed by: Bernstein Joshua
-
'A rare beauty in 2025': Bernstein sees upside potential in this HPC stock
-
PharmaEssentia Highlights Availability of BESREMi® (ropeginterferon alfa-2b-njft) for Patients Affected by Pegasys® (peginterferon alfa-2a) Drug Shortage
-
AutoZone misses quarterly revenue estimates on inflation, currency rates
-
Bernstein: 'Can US$100B Keep Intel at Arm's Length?'
-
Bernstein Reiterates Market Perform on Abbvie (ABBV) Following Gubra Agreement
-
Bernstein on NVIDIA (NVDA): 'Valuation Is Getting Increasingly Attractive'
-
Okta, Inc (OKTA) PT Raised to $132 at Bernstein SocGen Group
-
Bernstein: 'Still like Biohaven Pharmaceutical Holding (BHVN) Stock but No Longer a Top Pick'; PT Lowered
-
Bernstein: 'Eli Lilly (LLY) Continues to Outgrow Novo'
-
GitLab Inc (GTLB) PT Lowered to $76 at Bernstein SocGen Group
-
Bernstein SocGen Group Starts Titan America (TTAM) at Market Perform
-
Sea Ltd. (SE) Q4 earnings preview: e-commerce strength, gaming weakness in focus
-
Target stock: Breaking down the bull vs. bear case
-
Bernstein on Target (TGT): 'The Bull vs. Bear Case'
-
Sabre Corporation (SABR) PT Raised to $3.60 at Bernstein SocGen Group
-
KalVista Pharmaceuticals (KALV) Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
-
KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
-
Bernstein SocGen Group Reiterates Market Perform Rating on Intel (INTC)
-
Bernstein SocGen Group Downgrades Tandem Diabetes Care (TNDM) to Market Perform
-
Bernstein SocGen Group Upgrades Amadeus IT Group SA (AAD:GR) (AMADY) to Outperform
-
Bernstein SocGen Group Upgrades Amadeus IT Group SA (AMS:SM) (AMADY) to Outperform
-
Prosus-Just Eat: Bernstein addresses five investor questions on the deal
-
Global semiconductor outlook: NAND capex poised for recovery
-
Bernstein: Didi’s Robotaxi shows progress but challenges remain
-
Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025
-
Form X-17A-5/A SANFORD C. BERNSTEIN & For: Dec 31
-
Acadia Realty Trust Will Present at the Citi 2025 Global Property CEO Conference
-
Form X-17A-5 SANFORD C. BERNSTEIN & For: Dec 31
-
Bernstein on Eli Lilly (LLY) Amid US Biopharma Policy: 'LLY Leans In'
-
Bernstein: 'SGS SA (SGSN:SW) (SGSOY) Is Our Top Pick in the Sector'
-
Opmobility SE (OPM:FP) PT Raised to EUR8.60 at Bernstein; 'This is Not a Compelling Entry Point'
-
Bernstein SocGen Group Reiterates Underperform Rating on Pirelli & C. S.p.A. (PIRC:IM) (PLLIF)
-
Valeo SA (FR:FP) (VLEEY) PT Raised to EUR13 at Bernstein Following 'Broadly Positive' Results
-
Bernstein Reiterates Market Perform Rating on J.M. Smucker (SJM)
-
Just Eat Takeaway.com NV (TKWY:NA) (GRUB) PT Raised at Bernstein Amid Prosus Deal
-
Warner Brothers Discovery (WBD) PT Raised to $11 at Bernstein; 'A Better Setup for 2025'
-
Bernstein SocGen Group Downgrades Tandem Diabetes Care (TNDM) to Market Perform
-
Adidas targets larger US market share as Nike struggles
-
British Airways owner IAG profit beats estimates, plans share buyback
-
Form NPORT-P Bernstein Fund Inc For: Dec 31
-
Form NPORT-P Bernstein Fund Inc For: Dec 31
-
Form NPORT-P BERNSTEIN SANFORD C FUND For: Dec 31
-
Form NPORT-P BERNSTEIN SANFORD C FUND For: Dec 31
-
Form NPORT-P BERNSTEIN SANFORD C FUND For: Dec 31
-
Form NPORT-P BERNSTEIN SANFORD C FUND For: Dec 31
-
Form NPORT-P BERNSTEIN SANFORD C FUND For: Dec 31
-
Form NPORT-P BERNSTEIN SANFORD C FUND For: Dec 31

